Guardant Health's Tests Are Pioneering a Shift in Precision Oncology
Vanguards of Health Care by Bloomberg Intelligence
00:00
The Evolution of Genomic Sequencing and Its Impact on Cancer Treatment
This chapter explores the pivotal moment when genomic sequencing costs dropped to $1,000, sparking high hopes for disease treatment, particularly in cancer. It also highlights the challenges faced in deriving actionable insights from sequencing data and advocates for the integration of affordable, non-invasive testing methods in clinical practice.
Play episode from 05:22
Transcript
